Loading…
← CockpitCompetitor Analysis › 4736.TW Taidoc Technology CorporationOpen in the cockpit ↗

Taidoc Technology Corporation4736.TWCompetitor analysis, valuation and peers

Taiwan · TWD·Health Care›Medical Specialties
Momentum strong 71
Mkt cap
$387M
US dollars, full cap
Free float
70%
of shares outstanding
$/day
$742,169
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
+4.7 pp
WACC 5.0%
Hurdle
-3 pp
Req g minus delivered
Next earnings
132 days
30 Mar 2027
Close · TWDNT$124.00
1D-0.8%
1W-4.6%
1M-7.1%
3M-5.7%
6M+0.4%
YTD+2.1%
1Y+2.9%
ATR %2.3%
52w lowhigh15.1% off high

What Taidoc Technology does

No business profile yet.

Taidoc Technology at a glance

Size Taidoc Technology (4736.TW) is a Taiwan Health Care company (Medical Specialties) with a market value of $387M, the 518th largest of 648 Taiwan companies the cockpit tracks. Shares closed at NT$124.00 on 18 Nov 2026.

Performance Over six months the shares gained 0.4%, against -22.4% for the median peer and -3.4% for the Taiwan market (cap-weighted) — 5th highest of 20 in its peer set.

Growth Revenue fell 0.5% over the last twelve months (peer median +14.7%); the operating margin is 19.2% (peer median 4.2%).

Valuation It trades at 1.8× enterprise value to sales against a peer median of 4.1× (8th cheapest of 21).

Price implies For today's price to make sense, revenue must grow about -10% a year for seven years (Req g). Recent delivered growth is -7%, so the hurdle is -3 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 4.7 points above its cost of capital (5.0% WACC).

Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 20264736.TW 102Peer median 76
Six months, rebased to 100: Taidoc Technology against the median of its 20 peers (local-currency closes).

Taidoc Technology financials

Reported figures in TWD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueNT$4.32BNT$4.20BNT$4.64BNT$4.81BNT$9.63B
Revenue growth—-9%-3%-50%—
Gross profitNT$1.86BNT$1.90BNT$2.01BNT$2.02BNT$5.59B
EBITDANT$965MNT$1.10BNT$979MNT$1.20BNT$4.37B
Net incomeNT$2.26BNT$1.44BNT$1.16BNT$1.02BNT$3.38B
Free cash flowNT$738MNT$739MNT$734MNT$1.28BNT$3.77B
Capital expenditureNT$363MNT$251MNT$355MNT$114MNT$508M
Total debtNT$894MNT$1.16BNT$1.05BNT$1.09BNT$636M

Quarterly statements and history in the cockpit →

Taidoc Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+100%-40%-20%0%+20%002022CERS4588700418306929MASS3002386748BWAY688133CVSBS16093010974736.TW6-month return →1-month return →
Up and to the right = strong over both horizons. Taidoc Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%+150%0×10×20×002022CERS458870605186MASS3002386748BWAYCVSBS98773010974736.TWRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Taidoc Technology is the large dot.

Capital: growth delivered against growth the price implies

0%+100%+200%0%100%200%4588700418306929MASS2041300562BWAY4736.TWGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Taidoc Technology is the large dot.

Taidoc Technology competitors and peer comparison

How Taidoc Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Taidoc Technology against its 20 peers (data as of 18 Nov 2026)
Measure4736.TWPeer medianRank in peer set
1-month return-7.1%-12.6%5th highest of 21
6-month return+0.4%-22.4%5th highest of 20
Distance from 52-week high-15.1%-45.3%2nd highest of 21
Revenue growth (TTM)-0.5%+14.7%6th lowest of 21
Operating margin19.2%4.2%6th highest of 21
EV / Sales1.8×4.1×8th cheapest of 21
Growth the price implies (Req g, 7 yrs)-9.5%5.7%4th least demanding of 12
Growth delivered (Del g)-6.6%+15.9%lowest of 12
Hurdle (Req g minus delivered)-2.9 pp+1.8 pp5th least demanding of 12
ROIC minus cost of capital+4.7 pp-2.1 pp9th highest of 20
EV / EBITDA8.1×11.6×4th cheapest of 9
Net debt / EBITDA-5.5×-1.2×2nd least indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Taidoc Technology 4736.TWTaiwan$387M0%0%19%1.8×-9.5%-6.6%
Shanghai Kehua Bio-Engineering 002022.SZChina$389M-14%+7%-40%1.7×n/an/a
Cerus CERSUnited States$392M-28%+14%-12%1.8×n/an/a
SEERS 458870.KSSouth Korea$392M-70%+174%37%5.5×-6.3%+247.0%
InBody 041830.KSSouth Korea$380M-13%+22%22%1.4×-10.3%+16.9%
OrbusNeich Medical 6929.HKHong Kong$394M-15%+16%23%1.0×-17.6%+15.4%
Shanghai General Healthy Information & Technology 605186.SSChina$379M-26%-11%5%7.8×n/an/a
908 Devices MASSUnited States$396M+36%+14%-33%4.6×41.7%+15.9%
Medcaptain Medical Technology 2041.HKHong Kong$378Mn/a+19%2%1.5×17.1%+18.1%
Guanhao Biotech 300238.SZChina$397M-26%-12%3%7.1×n/an/a
ACRO Biomedical 6748.TWOTaiwan$377M+158%+45%-178%218.3×n/an/a
Guangdong Transtek Medical Electronics 300562.SZChina$373M-15%+7%11%1.8×-4.2%-6.0%
Brainsway Ltd Sponsored ADR BWAYUnited States$373M-41%+32%14%4.8×24.9%+18.8%
Shanghai Titan Scientific 688133.SSChina$403M-26%+1%-6%1.4×n/an/a
Chison Medical Technologies 688358.SSChina$406M-27%-1%19%3.9×9.6%+5.6%
CapsoVision CVUnited States$366M+5%+15%-213%24.8×n/an/a
Stratec SBS.DEGermany$365M+63%-6%4%1.8×19.1%+0.1%
Star Sports Medicine 1609.HKHong Kong$364M-73%+23%37%3.7×-13.1%+36.8%
Beijing Succeeder Technology 688338.SSChina$362M-18%-4%31%4.2×5.7%+3.4%
Jenscare Scientific 9877.HKHong Kong$415M-32%+993%-106%17.8×n/an/a
Ningbo Tianyi Medical Appliance 301097.SZChina$418M-22%+46%8%4.4×n/an/a

Questions

Which companies are Taidoc Technology's closest peers?
The cockpit's peer set: Shanghai Kehua Bio-Engineering (002022.SZ), Cerus (CERS), SEERS (458870.KS), InBody (041830.KS), OrbusNeich Medical (6929.HK), Shanghai General Healthy Information & Technology (605186.SS), 908 Devices (MASS), Medcaptain Medical Technology (2041.HK).
Is Taidoc Technology expensive compared with its peers?
On ev / sales it trades at 1.8× against a peer median of 4.1×, 8th cheapest of 21 in its peer set. For today's price to make sense, revenue must grow about -10% a year for seven years (Req g). Recent delivered growth is -7%, so the hurdle is -3 pp: the price already allows for a slowdown.
How has Taidoc Technology stock performed?
Over six months to 18 Nov 2026 the shares returned +0.4% against -22.4% for the median peer; over one year +2.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.